The IRRDC team
The IRRDC fosters global collaboration between patients, families, physicians and scientists. Our main goal is to investigate causes, implement clinical management and develop novel treatments for children and adults with Lynch Syndrome, Constitutional Mismatch Repair Deficiency (CMMRD), and polymerase proofreading deficient cancer syndromes.
The IRRDC operates internationally and includes more than 300 collaborators from over 50 countries. A governance committee is made up of the team members listed below. This committee helps to direct our research and establish new partnerships.”
Members of the IRRDC at our Annual RRD Workshop in 2017.